Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Cash from Investing Activities (2018 - 2025)

TELA Bio (TELA) has 8 years of Cash from Investing Activities data on record, last reported at $312000.0 in Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 355.74% year-over-year to $312000.0; the TTM value through Sep 2025 reached $464000.0, down 89.57%, while the annual FY2024 figure was $4.5 million, 843.07% up from the prior year.
  • Cash from Investing Activities reached $312000.0 in Q3 2025 per TELA's latest filing, up from $204000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $4.7 million in Q1 2024 and bottomed at -$1.0 million in Q4 2022.
  • Average Cash from Investing Activities over 5 years is $105631.6, with a median of -$134000.0 recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: plummeted 1427.27% in 2022, then soared 4183.48% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$289000.0 in 2021, then plummeted by 261.94% to -$1.0 million in 2022, then surged by 81.55% to -$193000.0 in 2023, then grew by 1.55% to -$190000.0 in 2024, then skyrocketed by 264.21% to $312000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $312000.0 in Q3 2025, $204000.0 in Q2 2025, and $138000.0 in Q1 2025.